Hodgkin Lymphoma Classical Type

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-10-02
Clinical Trial Update: A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205] [Phase 2]
A Phase 2 master protocol evaluating SAR-444245 for relapsed or refractory B-cell lymphoma was terminated; results have been posted.